Cardiovascular Systems, Inc.

CSII · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$7,888-$10,631-$9,690-$9,658
Dep. & Amort.$1,268$1,220$1,198$1,286
Deferred Tax$0-$0$0$0
Stock-Based Comp.$3,547$4,438$4,037$3,892
Change in WC-$52-$8,468-$5,634$2,387
Other Non-Cash-$423-$211$260-$35
Operating Cash Flow-$3,548-$13,652-$9,829-$2,128
Investing Activities
PP&E Inv.-$2,039-$688-$1,000-$794
Net Acquisitions-$7,965-$575$9,674-$675
Inv. Purchases-$20,760-$31,763-$39,247-$34,232
Inv. Sales/Matur.$29,900$44,364$38,250$39,076
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$864$11,338$7,677$3,375
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,476-$1,260$1,623-$159
Financing Cash Flow$1,405-$1,260$1,623-$159
Forex Effect$0$0$0$0
Net Chg. in Cash-$3,007-$3,574-$529$1,088
Supplemental Information
Beg. Cash$62,850$66,424$66,953$65,865
End Cash$59,843$62,850$66,424$66,953
Free Cash Flow-$5,587-$14,340-$10,829-$2,922